| The investigation by the House Oversight Committee shows that pharmaceutical companies studied by the committee raised prices of common brand-name drugs during the past five years by nearly four times the rate of inflation. An industry trade group said the congressional investigation ignored the "real affordability problems" consumers face, including rising deductibles and other out-of-pocket costs. | 
No comments:
Post a Comment